Univ. of Chicago and Harvard Medical School. Phosphonoformic acid (PFA) and its congener phosphonoacetic acid (PAAI arc inhibitors of viral (and to a less axtent mammalian) DNA polymerase. We selected mutants of 549 cells (a mouse T lymphoma line) resistant to 3mM phosphonoformic acid. These 11 1i:ies had a range of growth rates, cell cycle distribution abnormalities, and concomitant resistance to the inhibitory effects of thymicline, acycloguanosine (acyclovir), aphidicolin, deoxyadenosine, and novobiocin. Most lines had normal to sliqhtly elevated pools of ribonucleoside triphosphates and deoxyribonucleoside triphosphates. However, one line (PFA 3-9) had a greatly elevated dCTP pool and increased CDP reducatase act;vity i~; perneabilized cells. This activity in the PFA 3-9 cells diminished to wild type 'control levels in the presence of phosphonoformic acid. while PFA greatly diminished wild type CDP reductase activity (see  table) . In addition, 4mM PFA diminished the dCT? pool in wild type and in PFA 3-9 cells at 8 hours. The reduced dCTP pool could be increased by exoqenous deoxycytidine but this only marginally reversed PFA toxicity. These observations suqgest that PFA is an inhibitor of mammalian ribonucleotide reductase and partial resistance to PFA can be effected by mutation to increased CDP reductase activity resulting in a large dCTP pool.
Growth Chicago and lfarvard Medical School. We selected hydroxyurea resistant S49T lymphoma cells by exposing wild type cells to increasing concentrations of hydroxyureaan inhibitor of ribonucleotide reductase that binds to the M2 subunit of the enzyme. These lot060 fold resistant cell lines demonstrated increased ribonucleotide reductase activity and deoxyribonucleoside triphosphate pools consistent with thehypothesis that the activity of the M2 subunit of ribonucleotidereductase is rate limiting for both ribonucleotide reductaseactivity and deoxyribonucleoside triphosphate production. Assay of partially purified cell extracts containing M1 or M2 demonstrated the increased M2 activity in HYU resistant cells. Twodimensional gel electrophoresis demonstrated a single spot of increased intensity(pI=5.5 M.W. 50K daltonslin HYU resistant cells which was proportional to the increased M2 activity. In addition hydroxyurea resistant cells were partially resistant to deoxyadenosinetoxicity. Cytoflourimetry of HYU resistant cells showed a normal cell cycle distribution which was unchanged after exposure to dibutyryl cyclic AMP in contrast to wild type S49 cells which accumulate in G1(>90%). Similarly hydroxyurea resistant cells did not arrest in G1 when exposed to Forskolin as wild type S49 cells do. However, both hydroxyurea resistant and wild type cells were arrested inG1 phase with the phosphodiesterase inhibitor R0-1724. These data suggest that hydroxyurea resistant cells have increased ribonucleo -tide reductase activity due to increased M2 activity, possibly secondary to amplified genes(s) and exhibit abnormalities in cyclic AMP response. Hospital for Sick Children, Toronto, Ontario, Canada. W i n e de novo synthesis and salvage occur in the testis. Cell division accelerates at puberty. We have correlated changes in the activity of purine de novo synthesis and purine salvage with the histology of the developing testis and with serum hormone levels. Purine de novo synthesis peaked at 17 days and IIF'RT activity at 35 days. APRT activity decreased at 17 days and remained very low. The 17 day peak of purine novo synthesis coincided exactly with the appearance of --sfiermatids and prominent spermatocytic meiosis. The 35 day H P W peak coincided with the first appearance of active spermatogenesis, full thickness of precursor cells and fully fledged spermatozoa. These findings indicate that the full developmen? of reproductive function in the male requires HPRT as well ss purine de novo synthesis.
The effect of interferon on nucleic acid synthesis and on nucleotide metabolism was studied in human ~-1~m~hoblastoid cells. Cells were incubated with 50 units/ml of recdmbinant a-interferon for 24 hrs. Synthesis of nucleic acids, ribonucleotides, deoxyribonucleotides as well as nucleotide interconversion and catabolism were determined. Interferon inhibited botli DNA and RNA synthesis measured by the incorporation of radioactive thymidine and uridine respectively. Ribonucleotide and deoxyribonucleotide biosynthesis by both the de novo and salvage pathways was markedly inhibited by interferon whereas nucleotide catabolism was significantly increased. Interferon also decreased intracellular PRPP levels but had no effect on ribonucleotide interconversion or protein synthesis measured by incorporation of radioactive threonine, leucine and valine. These results showed that inhibition of nucleic acid synthesis by interferon is associated with decreased availability of nucleotides for synthesis of both DNA and RNA.
